Category: General Biotechnology

Upcoming talk: Forget everything you thought you knew about biotechnology entrepreneurship

I’ll be at Rutgers on February 29th, giving a talk on biotechnology entrepreneurship. My objective is to dispel the popular notions about how biotechnology entrepreneurship occurs, and to provide case studies demonstrating the diversity of methods by which biotechnology entrepreneurs start and build their businesses. I’ll also provide some case studies of significant mis-steps, with […]


An appeal for generic biologic legislation

The following appeal for generic biologic legislation was sent in from Insmed via youtube. I’ve posted previously on the challenges of developing a framework for generic biologic approvals and questioned how much we can really expect to save. In the editorial for the upcoming issue of the Journal of Commercial Biotechnology, I argue that the […]


Drug Patent Expirations in February 2008

Courtesy of DrugPatentWatch.com: Drug Patent Expirations in February 2008*Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration CAMPTOSAR Pfizer Inc irinotecan hydrochloride 4,604,463 FEB 20,2008 CIPRO HC Alcon ciprofloxacin hydrochloride; hydrocortisone 4,844,902 FEB 11,2008 CIPRODEX Alcon ciprofloxacin; dexamethasone 4,844,902 FEB 11,2008 DEPOCYT Pacira Pharms Inc cytarabine 6,071,534 FEB 18,2008 […]


New Biotechnology Books

Two new biotechnology books due out in March 2008: [AMAZONPRODUCT=0973467673] Best Practices in Biotechnology Education 22 International Best Practices in K-12, College, Certificate, Master’s, Doctoral, MBA, Distance Education Programs and Student Groups First Edition, March 2008 Perfect Bound, 342 pages, US$74.95 ISBN: 978-09734676-7-3 Best Practices in Biotechnology Education is directed at faculty seeking to start […]


Want biotechnology venture capital? Use a shotgun!

On returning from a meeting with a small biotechnology firm in which I serve on the advisory board, I was reminded of a novel strategy for attracting venture capital. One of the challenges is attracting investment is finding an investor aligned with your company’s future directions. Venture capitalists may be interested only in large companies, […]


Journal of Commercial Biotechnology – January 2008

After months of work, the January issue of the Journal of Commercial Biotechnology, my first as managing editor, has just been published. The links below will take you to each article: Volume 14, Issue 1 Editorial Editorial PDF Yali Friedman Articles The ability to pick biotech talent: Being a better interviewer moves ‘you’ up the […]


Drug Patent Expirations in January 2008

Courtesy of DrugPatentWatch.com: Drug Patent Expirations in January 2008*Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration CARDIOLITE Bristol Myers Squibb technetium tc-99m sestamibi kit 4,988,827 JAN 29,2008 CHILDREN’S ADVIL Wyeth Cons ibuprofen 4,788,220 JAN 08,2008 COVERA-HS Gd Searle Llc verapamil hydrochloride 5,200,196 JAN 22,2008 DEPAKOTE Abbott divalproex sodium […]


Biotechnology in Turkey

My recent presentation at the “Biotechnology for Turkey” conference has been posted online. My central thesis was that the challenges faced by Turkey (and most any other location) are shared by many states within the United States. I’ve heard too many people opine for the seemingly easy start-up environment in the United States. The reality […]


FDA Enforcement Trends: 2007-2008

Guest content from John Avellanet, managing director of Cerulean Associates: The US Food and Drug Administration (FDA) intends to increase regulatory enforcement, extending the recent trend of laboratory and clinical site inspections to unapproved drugs and reformulations. How can you avoid compliance trouble? At the Food and Drug Law Institute’s 5th Annual Enforcement and Litigation […]


Drug Patent Expirations in December 2007

Courtesy of DrugPatentWatch.com: Drug Patent Expirations in December 2007*Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration DOVONEX Leo Pharm calcipotriene 4,866,048 DEC 29,2007 FASLODEX Astrazeneca fulvestrant 4,659,516 DEC 11,2007 KYTRIL Roche granisetron hydrochloride 4,886,808 DEC 20,2007 KYTRIL Roche granisetron hydrochloride 4,886,808 DEC 29,2007 MERIDIA Abbott sibutramine hydrochloride 4,746,680 […]


Do NOT follow this link or you will be banned from the site!
%d bloggers like this: